Modulation of microRNA expression in human lung cancer cells by the G9a histone methyltransferase inhibitor BIX01294

Pang,Alan Lap‑Yin; Title,Alexandra C.; Rennert,Owen M.

doi:10.3892/ol.2014.2034

Modulation of microRNA expression in human lung cancer cells by the G9a histone methyltransferase inhibitor BIX01294

Authors:
- Alan Lap‑Yin Pang
- Alexandra C. Title
- Owen M. Rennert
View Affiliations

Affiliations: Laboratory of Clinical and Developmental Genomics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892‑4429, USA
Published online on: April 4, 2014 https://doi.org/10.3892/ol.2014.2034
Pages: 1819-1825

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) are small non‑coding RNAs that regulate the expression of their target genes at the post‑transcriptional level. In cancer cells, miRNAs, depending on the biological functions of their target genes, may have a tumor‑promoting or ‑suppressing effect. Treatment of cancer cells with inhibitors of DNA methylation and/or histone deacetylation modulates the expression level of miRNAs, which provides evidence for epigenetic regulation of miRNA expression. The consequences of inhibition of histone methyltransferase on miRNA expression, however, have not been thoroughly investigated. The present study examined the expression pattern of miRNAs in the non‑small cell lung cancer cell line, H1299 with or without treatment of BIX01294, a potent chemical inhibitor of G9a methyltransferase that catalyzes the mono‑and di‑methylation of the lysine 9 residue of histone H3. By coupling microarray analysis with quantitative real‑time polymerase chain reaction analysis, two miRNAs were identified that showed consistent downregulation following BIX01294 treatment. The results indicate that histone H3 methylation regulates miRNA expression in lung cancer cells, which may provide additional insight for future chemical treatment of lung cancer.

View Figures

View References

1	American Cancer Society. Lung Cancer (Non-Small Cell). http://www.cancer.org/cancer/lungcancer-non-smallcell/detaile-dguide/non-small-cell-lung-cancer-key-statistics. Accessed August 16, 2013
2	Geutjes EJ, Bajpe PK and Bernards R: Targeting the epigenome for treatment of cancer. Oncogene. 31:3827–3844. 2012. View Article : Google Scholar : PubMed/NCBI
3	Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF and Minna JD: Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res. 61:249–255. 2001.PubMed/NCBI
4	Hur K, Cejas P, Feliu J, et al: Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut. 63:635–646. 2014. View Article : Google Scholar : PubMed/NCBI
5	Jung KH, Noh JH, Kim JK, et al: HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins. J Cell Biochem. 113:2167–2177. 2012. View Article : Google Scholar : PubMed/NCBI
6	Hayashi A, Horiuchi A, Kikuchi N, et al: Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin. Int J Cancer. 127:1332–1346. 2010. View Article : Google Scholar : PubMed/NCBI
7	Lujambio A and Esteller M: How epigenetics can explain human metastasis: a new role for microRNAs. Cell Cycle. 8:377–382. 2009. View Article : Google Scholar : PubMed/NCBI
8	Baer C, Claus R and Plass C: Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477. 2013. View Article : Google Scholar : PubMed/NCBI
9	He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature. 435:828–833. 2005. View Article : Google Scholar : PubMed/NCBI
10	Song SJ, Ito K, Ala U, et al: The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell. 13:87–101. 2013. View Article : Google Scholar : PubMed/NCBI
11	Chen P, Price C, Li Z, et al: miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia. Proc Natl Acad Sci USA. 110:11511–11516. 2013. View Article : Google Scholar : PubMed/NCBI
12	Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
13	Cimmino A, Calin GA, Fabbri M, et al: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
14	Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y and Yin LR: MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1. FEBS J. 280:3768–3779. 2013. View Article : Google Scholar : PubMed/NCBI
15	Rhodes LV, Nitschke AM, Segar HC, et al: The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. Oncol Rep. 27:10–16. 2012.
16	Scott GK, Mattie MD, Berger CE, Benz SC and Benz CC: Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res. 66:1277–1281. 2006. View Article : Google Scholar : PubMed/NCBI
17	Chatterjee N, Wang WL, Conklin T, Chittur S and Tenniswood M: Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase and induce apoptosis in inflammatory breast cancer cells. Cancer Biol Ther. 14:658–671. 2013. View Article : Google Scholar
18	Bandres E, Agirre X, Bitarte N, et al: Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
19	Saito Y, Liang G, Egger G, et al: Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI
20	Lee EM, Shin S, Cha HJ, et al: Suberoylanilide hydroxamic acid (SAHA) changes microRNA expression profiles in A549 human non-small cell lung cancer cells. Int J Mol Med. 24:45–50. 2009.PubMed/NCBI
21	Heller G, Weinzierl M, Noll C, et al: Genome-wide miRNA expression profiling identifies miR-9–3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. Clin Cancer Res. 18:1619–1629. 2012.
22	Rice JC, Briggs SD, Ueberheide B, et al: Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell. 12:1591–1598. 2003. View Article : Google Scholar
23	Tachibana M, Sugimoto K, Nozaki M, et al: G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 16:1779–1791. 2002. View Article : Google Scholar : PubMed/NCBI
24	Huang J, Dorsey J, Chuikov S, et al: G9a and Glp methylate lysine 373 in the tumor suppressor p53. J Biol Chem. 285:9636–9641. 2010. View Article : Google Scholar : PubMed/NCBI
25	Kondo Y, Shen L, Suzuki S, et al: Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Hepatol Res. 37:974–983. 2007. View Article : Google Scholar : PubMed/NCBI
26	Nguyen CT, Weisenberger DJ, Velicescu M, et al: Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res. 62:6456–6461. 2002.PubMed/NCBI
27	McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T and Baylin SB: Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res. 66:3541–3549. 2006. View Article : Google Scholar
28	Chen MW, Hua KT, Kao HJ, et al: H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 70:7830–7840. 2010. View Article : Google Scholar : PubMed/NCBI
29	Kondo Y, Shen L, Ahmed S, et al: Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS One. 3:e20372008. View Article : Google Scholar : PubMed/NCBI
30	Kubicek S, O’Sullivan RJ, August EM, et al: Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell. 25:473–481. 2007. View Article : Google Scholar : PubMed/NCBI
31	Lu Z, Tian Y, Salwen HR, et al: Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells. Anticancer Drugs. 24:484–493. 2013. View Article : Google Scholar : PubMed/NCBI
32	Wang X: miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA. 14:1012–1017. 2008. View Article : Google Scholar : PubMed/NCBI
33	Wang X and El Naqa IM: Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics. 24:325–332. 2008. View Article : Google Scholar : PubMed/NCBI
34	Wang J, Duncan D, Shi Z and Zhang B: WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 41:W77–W83. 2013. View Article : Google Scholar : PubMed/NCBI
35	Validation of miRNA Microarray Results with Real-Time qPCR. Technical Bulletin. LC Sciences; Houston, TX, USA:
36	Law FB, Chen YW, Wong KY, et al: Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma. Oncogene. 26:5877–5888. 2007. View Article : Google Scholar
37	Nagel S, Leich E, Quentmeier H, et al: Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma. Leukemia. 22:387–392. 2008. View Article : Google Scholar
38	Kwei KA, Shain AH, Bair R, et al: SMURF1 amplification promotes invasiveness in pancreatic cancer. PLoS One. 6:e239242011. View Article : Google Scholar : PubMed/NCBI
39	Mu D, Chen L, Zhang X, et al: Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell. 3:297–302. 2003. View Article : Google Scholar : PubMed/NCBI
40	Ho JC, Cheung ST, Patil M, Chen X and Fan ST: Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma. Int J Cancer. 119:1330–1337. 2006. View Article : Google Scholar
41	Kan T, Sato F, Ito T, et al: The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology. 136:1689–1700. 2009. View Article : Google Scholar : PubMed/NCBI
42	Long MJ, Wu FX, Li P, Liu M, Li X and Tang H: MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. Cancer Lett. 324:186–196. 2012. View Article : Google Scholar : PubMed/NCBI
43	John AS, Hu X, Rothman VL and Tuszynski GP: Thrombospondin-1 (TSP-1) up-regulates tissue inhibitor of metalloproteinase-1 (TIMP-1) production in human tumor cells: exploring the functional significance in tumor cell invasion. Exp Mol Pathol. 87:184–188. 2009. View Article : Google Scholar
44	Espejo R, Rengifo-Cam W, Schaller MD, Evers BM and Sastry SK: PTP-PEST controls motility, adherens junction assembly, and Rho GTPase activity in colon cancer cells. Am J Physiol Cell Physiol. 299:C454–C463. 2010. View Article : Google Scholar : PubMed/NCBI
45	Tan KD, Zhu Y, Tan HK, et al: Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma. Genes Chromosomes Cancer. 47:353–362. 2008. View Article : Google Scholar : PubMed/NCBI
46	Zhou Q, Huang T, Wang YF, Zhang KS, Chen D and Peng BG: Identification of Max binding protein as a novel binding protein of Nck1 and characterization of its role in inhibiting human liver cancer SK-HEP-1 cells. Chin Med J (Engl). 125:3336–3339. 2012.PubMed/NCBI
47	Penna E, Orso F, Cimino D, et al: microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J. 30:1990–2007. 2011. View Article : Google Scholar : PubMed/NCBI